NASDAQ · Biotechnology

IVVD (IVVD) Stock

$0.55 +3.10% NASDAQ: IVVD Healthcare

Valuation

MetricValue
Price$0.55
Market Cap$162.51M
P/E Ratio-3.53
P/B Ratio0.58
P/S Ratio2.59
EPS (TTM)$-0.30
52-Week High$3.07
52-Week Low$0.48
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-21.49%
ROA-18.77%
ROCE-23.14%
Gross Margin-105.66%
Operating Margin-105.66%
Net Margin-1.39%
Debt/Equity0.04
Current Ratio7.26

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$25.0M$53.0M
Operating Profit$-227.0M$-248.0M$-213.0M$-177.0M$-56.0M
Net Profit$-227.0M$-241.0M$-199.0M$-170.0M$-52.0M
EPS$-2.11$-2.17$-1.81$-1.43$-0.30
Op Margin———-696.8%-104.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$620.0M$383.0M$229.0M$130.0M$277.0M
Total Liabilities$62.0M$27.0M$52.0M$62.0M$35.0M
Cash$542.0M$92.0M$201.0M$69.0M$227.0M
Borrowings$0$4.0M$2.0M$1.0M$2.0M

Latest News

IVVD Stock Drops As PEMGARDA Loses Emergency Authorization In 2027 — Invivyd Eyes Full FDA Approval Stocktwits · Jul 6, 2026 Invivyd Gets FDA Notice of Pemgarda COVID-19 Emergency Use Authorization Termination MT Newswires · Jul 6, 2026 Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA GlobeNewswire · Jul 6, 2026 Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 2, 2026 NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer GlobeNewswire · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-185.0M$-220.0M$-173.0M$-170.0M$-58.0M
Investing Cash Flow$-51.0M$-232.0M$280.0M$0$0
Financing Cash Flow$-3.0M$1.0M$1.0M$0$0
Net Cash Flow$427.0M$-450.0M$109.0M$-131.0M$157.0M
Free Cash Flow$-185.0M$-222.0M$-174.0M$-171.0M$-58.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-54.92%
Quick Ratio5.67
Interest Coverage—
Return 1Y10.18%
Return 3Y-42.37%
Return 5Y—

Ownership

Insiders Held7.07%
Institutions Held83.97%
Institutions Float Held90.36%
Institutional HolderSharesReport Date
Janus Henderson Group PLC33,094,3302026-03-31
Perceptive Advisors Llc20,859,3032026-03-31
BVF Inc.19,525,0002026-03-31
Maverick Capital Ltd.18,970,9132026-03-31
Saturn V Capital Management LP10,949,0842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CCCC $3.52 -0.85% -2.54 $389.20M 0.00%
CDXS $1.47 -2.00% -5.06 $133.62M 0.00%
GNFTGenfit S.A. $8.95 +4.07% 261.07 $445.68M 0.00%
IMDXInsight Molecular Diagnostics Inc. $4.70 -0.84% -3.13 $151.76M 0.00%
NTHINeonc Technologies Holdings, Inc. $3.44 +0.29% -1.77 $89.21M 0.00%

About IVVD

IVVD is led by CEO William E. Duke Jr., employs 99 people, headquartered in US, publicly traded since 2021.

IVVD stock trades at $0.55 with a market capitalization of $162.51M. The stock is valued at a price-to-earnings (P/E) ratio of -3.53, price-to-book of 0.58, price-to-sales of 2.59. Over the past 52 weeks the stock has ranged between $0.48 and $3.07, and currently trades 82.1% below its 52-week high.

On profitability, IVVD generates a return on equity (ROE) of -21.49%, return on capital employed of -23.14%, an operating margin of -105.66%, a net profit margin of -1.39%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides